EUVIMEDEUVIMED entdecken
Kohortenstudie

Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study

Maria Fernanda Zavala-Miranda, Ana María Sobrino-Vargas, Adriana Hernández-Andrade, Valeria Caballero-Malacara, Abril A Pérez-Arias, Sofía E Márquez-Macedo, Alberto Nordmann-Gomes, Valeria Navarro-Sánchez, Bernardo Juárez-Cuevas, Norma O Uribe-Uribe, Juan M Mejia-Vilet

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-07043-x ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Maria Fernanda Zavala-Miranda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario …. Hauptthemen laut MEDLINE: Lupus Nephritis, Glomerular Filtration Rate, Kidney, Disease Progression. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION/OBJECTIVES: The heterodimer exostosin-1/exostosin-2 (EXO-1/2) is a novel antigen observed in membranous nephropathy associated with systemic lupus erythematosus. This study aimed to evaluate the association between EXO-1/2 positivity in kidney biopsy and kidney outcomes. METHODS: The kidney biopsy tissue from 50 class 5 lupus nephritis (LN) and 55 mixed class 3/4 + 5 LN patients was stained for EXO-1/2. Baseline clinical and histological characteristics were compared between EXO-1/2 positive and EXO-1/2 negative patients. Time-to-event analyses were performed to compare rates of response to therapy, kidney flares, and progression to a 40% decline of the glomerular filtration rate (eGFR), doubling of serum creatinine, and kidney failure. RESULTS: Fourteen out of 50 (28%) of class 5 and 5 out of 55 (9%) of mixed class 3/4 + 5 LN stained positive for EXO-1/2. Patients with class 5 LN and EXO-1/2 positive stain were younger, with better kidney function at presentation, and lower scarring in the kidney biopsy analysis. Over a median follow-up of 100 months, patients with positive EXO-1/2 staining had significantly lower rates of progression in the full cohort. When analyzed separately in class 5 and mixed class LN subgroups, there were significantly lower rates of progression to a 40% decline of the eGFR and non-statistically significant trends for doubling of serum creatinine and kidney failure. CONCLUSION: EXO-1/2 is a novel antigen detected in class 5 LN and associated with a good prognosis of kidney function. The incorporation of EXO-1/2 staining in clinical practice can potentially modify the management of LN due to its prognostic implications. Key Points • Exostosin-1/exostosin-2 antigen has been found in cases of membranous nephropathy associated with autoimmune diseases such as systemic lupus erythematosus. • Exostosin-1/exostosin-2 staining in the kidney biopsy of class 5 or mixed class 3/4 + 5 lupus nephritis is associated with a good long-term prognosis of kidney function. • The incorporation of exostosin-1/exostosin-2 staining into clinical practice can potentially modify management due to its prognostic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisGlomerular Filtration RateKidneyDisease ProgressionHumansFemaleMaleAdultRetrospective StudiesMiddle AgedBiopsyYoung AdultN-AcetylglucosaminyltransferasesExostosin 2Exostosin 1

Stichwörter der Autor:innen

ErythematosusExostosinLupus nephritisMembranous nephropathyPrognosisSystemic lupus

Substanzen

Exostosin 1Exostosin 2N-Acetylglucosaminyltransferases

Autor:innen und Institutionen

  • Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Sección XVI, Tlalpan, 14080, Mexico City, Mexico.
  • Department of Pathology and Anatomic Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Sección XVI, Tlalpan, 14080, Mexico City, Mexico. juan.mejia…

Zitieren

APA

Zavala-Miranda, M. F., Sobrino-Vargas, A. M., Hernández-Andrade, A., Caballero-Malacara, V., Pérez-Arias, A. A., Márquez-Macedo, S. E., Nordmann-Gomes, A., Navarro-Sánchez, V., Juárez-Cuevas, B., Uribe-Uribe, N. O., & Mejia-Vilet, J. M. (2024). Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07043-x

Vancouver

Zavala-Miranda MF, Sobrino-Vargas AM, Hernández-Andrade A, Caballero-Malacara V, Pérez-Arias AA, Márquez-Macedo SE, et al. Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07043-x

BibTeX
@article{ZavalaMiranda2024,
  author = {Zavala-Miranda, Maria Fernanda and Sobrino-Vargas, Ana María and Hernández-Andrade, Adriana and Caballero-Malacara, Valeria and Pérez-Arias, Abril A and Márquez-Macedo, Sofía E and Nordmann-Gomes, Alberto and Navarro-Sánchez, Valeria and Juárez-Cuevas, Bernardo and Uribe-Uribe, Norma O and Mejia-Vilet, Juan M},
  title = {Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-07043-x}
}
Kostenlos starten →